A case report of BCR-ABL(+) acute myeloid leukemia and literature review
Frontiers in Oncology · 14.04.2026 · 16
DOI: 10.3389/fonc.2026.1772154 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 14.04.2026. Verfasst von Jianping Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BCR-ABL(+) acute myeloid leukemia (AML) is considered a rare AML subtype with a short median survival time and poor prognosis. Currently, there is no unified standard treatment regimen for this disease, which complicates clinical diagnosis, treatment and medication selection. Case reports on this AML subtype remain relatively scarce to date. In this study, we present a case of BCR-ABL(+) AML that was treated with a TKI in combination with chemotherapy to induce remission, followed by allogeneic hematopoietic stem cell transplantation (Allo-HSCT). We also review the relevant literature to shed light on treatment strategies for BCR-ABL(+) AML and provide strong support for Allo-HSCT as a therapeutic option for this subtype.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Zitieren
APA
Li, J., Zheng, W., Dong, X., Wang, J., & Liu, K. (2026). A case report of BCR-ABL(+) acute myeloid leukemia and literature review. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1772154
Vancouver
Li J, Zheng W, Dong X, Wang J, Liu K. A case report of BCR-ABL(+) acute myeloid leukemia and literature review. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1772154
BibTeX
@article{Li2026,
author = {Li, Jianping and Zheng, Wei and Dong, Xueyan and Wang, Jingyi and Liu, Kui},
title = {A case report of BCR-ABL(+) acute myeloid leukemia and literature review},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1772154}
}
EUVIMED